{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:56:33Z","timestamp":1791244593017,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by the Changzhou Sci&Tech Program","award":["Grant No. CJ20230001"],"award-info":[{"award-number":["Grant No. CJ20230001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60643-2","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:26:32Z","timestamp":1783347992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SLC25A43 in hepatocellular carcinoma: bioinformatics insights into progression and immune microenvironment"],"prefix":"10.1038","volume":"16","author":[{"given":"Dunzhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichang","family":"zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"4","key":"60643_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 18 (4), 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"60643_CR2","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal, F. et al. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology 155 (6), 1828\u201337e2 (2018).","journal-title":"Gastroenterology"},{"issue":"1","key":"60643_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (1), 73\u201384 (2016).","journal-title":"Hepatology"},{"issue":"1","key":"60643_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang, D. Q., Mathurin, P., Cortez-Pinto, H. & Loomba, R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat. Rev. Gastroenterol. Hepatol. 20 (1), 37\u201349 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"60643_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jhep.2024.06.042","volume":"82","author":"MS Rezaee-Zavareh","year":"2025","unstructured":"Rezaee-Zavareh, M. S. et al. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis. J. Hepatol. 82 (1), 107\u2013119 (2025).","journal-title":"J. Hepatol."},{"issue":"10","key":"60643_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet, J. M., Montal, R., Sia, D. & Finn, R. S. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 15 (10), 599\u2013616 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"60643_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","volume":"5","author":"A Huang","year":"2020","unstructured":"Huang, A., Yang, X. R., Chung, W. Y., Dennison, A. R. & Zhou, J. Targeted therapy for hepatocellular carcinoma. Signal. Transduct. Target. Ther. 5 (1), 146 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"60643_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang, W. et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal. Transduct. Target. Ther. 5 (1), 87 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"27","key":"60643_CR9","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/JCO.21.00163","volume":"39","author":"S Qin","year":"2021","unstructured":"Qin, S. et al. Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial. J. Clin. Oncol. 39 (27), 3002\u20133011 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"7854","key":"60643_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister, D. et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592 (7854), 450\u2013456 (2021).","journal-title":"Nature"},{"issue":"1","key":"60643_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen, K. Y., Zhu, Y., Xie, S. Z. & Qin, L. X. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J. Hematol. Oncol. 17 (1), 25 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"60643_CR12","doi-asserted-by":"crossref","unstructured":"Luo, X. et al. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024;5(2):e474. (2020).","DOI":"10.1002\/mco2.474"},{"issue":"2","key":"60643_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2021.09.035","volume":"76","author":"B Scheiner","year":"2022","unstructured":"Scheiner, B. et al. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. J. Hepatol. 76 (2), 353\u2013363 (2022).","journal-title":"J. Hepatol."},{"issue":"2","key":"60643_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","volume":"72","author":"AL Cheng","year":"2020","unstructured":"Cheng, A. L., Hsu, C., Chan, S. L., Choo, S. P. & Kudo, M. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J. Hepatol. 72(2), 307\u201319 (2020).","journal-title":"J. Hepatol."},{"key":"60643_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102955","volume":"137","author":"G Cabibbo","year":"2025","unstructured":"Cabibbo, G. et al. The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers. Cancer Treat. Rev. 137, 102955 (2025).","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"60643_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41419-022-04738-4","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Genome-wide screening in the haploid system reveals Slc25a43 as a target gene of oxidative toxicity. Cell. Death Dis. 13 (3), 284 (2022).","journal-title":"Cell. Death Dis."},{"key":"60643_CR17","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Integrated Analysis of RNA-Binding Proteins in Glioma. Cancers (Basel) ;12(4). (2020).","DOI":"10.3390\/cancers12040892"},{"issue":"23","key":"60643_CR18","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann, D. et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell 186(23), 5068\u201383 e23 (2023).","journal-title":"Cell"},{"issue":"6","key":"60643_CR19","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.immuni.2025.05.006","volume":"58","author":"ZY Liu","year":"2025","unstructured":"Liu, Z. Y. et al. Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy. Immunity 58(6), 1572\u201385 e10 (2025).","journal-title":"Immunity"},{"issue":"1","key":"60643_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12859-025-06051-1","volume":"26","author":"L Kennedy","year":"2025","unstructured":"Kennedy, L., Sandhu, J. K., Harper, M. E. & Cuperlovic-Culf, M. A hybrid machine learning framework for functional annotation of mitochondrial glutathione transport and metabolism proteins in cancers. BMC Bioinform. 26 (1), 48 (2025).","journal-title":"BMC Bioinform."},{"issue":"1","key":"60643_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-021-00594-4","volume":"6","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1beta in hepatocellular carcinoma. Signal. Transduct. Target. Ther. 6 (1), 190 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"60643_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.32702","volume":"78","author":"I Penuelas-Haro","year":"2023","unstructured":"Penuelas-Haro, I. et al. The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression. Hepatology 78 (2), 416\u2013433 (2023).","journal-title":"Hepatology"},{"key":"60643_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1714314","volume":"17","author":"J Li","year":"2026","unstructured":"Li, J. et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: Implications for postoperative recurrence risk. Front. Immunol. 17, 1714314 (2026).","journal-title":"Front. Immunol."},{"key":"60643_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2026.5729","author":"XM Chen","year":"2026","unstructured":"Chen, X. M. et al. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int. J. Mol. Med. https:\/\/doi.org\/10.3892\/ijmm.2026.5729 (2026).","journal-title":"Int. J. Mol. Med."},{"key":"60643_CR25","doi-asserted-by":"publisher","DOI":"10.1159\/000549355","author":"J Li","year":"2025","unstructured":"Li, J. et al. Rechallenge with immune checkpoint inhibitors in patients with hepatocellular carcinoma: A narrative review. Liver Cancer https:\/\/doi.org\/10.1159\/000549355 (2025).","journal-title":"Liver Cancer"},{"issue":"D1","key":"60643_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"60643_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"60643_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60643-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:30:43Z","timestamp":1791243043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60643-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60643"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60643-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31029"}}